Clinical Trials Browser

Completed × Solid Tumors × liposomal doxorubicin × Clear all

NCT01214668 2019-01-04

Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors

Phase 1 Completed

31 enrolled 17 charts

Other solid neoplasm

Solid Tumors

NCT01702129 2014-09-09

Anti-EGFR Immunoliposomes in Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00500422 2013-02-13

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

Phase 1 Completed

Other solid neoplasm

Solid Tumors